When was SanuWave founded?

SanuWave was founded in 2005 and raised its 1st funding round 4 years after it was founded.

Where is SanuWave located?

SanuWave is headquartered in Alpharetta, United States.

How many employees does SanuWave have?

As of Jun 30, 2026, the latest employee count at SanuWave is 80.

Is SanuWave a funded company?

SanuWave is a funded company, having raised a total of $1.43M across 19 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 17, 2009.

When was the latest funding round of SanuWave?

SanuWave's latest funding was a $***** Post IPO round on Jun 18, 2024, with participation from 0 investor.

What is the annual revenue of SanuWave?

Annual revenue of SanuWave is between $10M and $50M as on Dec 31, 2025

Where does SanuWave rank among its competitors?

SanuWave ranks 2nd amongst 206 active competitors, of which 45 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was BioStem Technologies, which secured $2.5M in May, 2026.

Who are the top competitors of SanuWave?

SanuWave's top competitors include SolasCure, Nuo Therapeutics and Sanara MedTech. Among them, BioStem Technologies secured the most recent funding round in May, 2026.

SanuWave - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Developer of Noninvasive devices, and biologics for wound healing. The products include the dermaPACE System an acoustic wave therapy for an advanced wound care, UltraMIST System an ultrasound therapy, orthoPACE system which utilizes PACE technology for the treatment of chronic pain caused by musculoskeletal disorders and inflammatory conditions. The biologics include Biovance and Interfyl for the treatment of damaged tissues.

Key Metrics

Founded Year

2005

Location

Alpharetta, United States

Stage

Public

Total Funding

$1.43M in 19 rounds

Latest Funding Round

Post IPO, Jun 18, 2024, $*****

Investors

CIT & 1 more

Ranked

2^nd among 206 active competitors

Annual Revenue

$10M - $50M as on Dec 31, 2025

Employee Count

80 as on Jun 30, 2026

Similar Companies

SolasCure & 239 more

Exit Details

Public

View SanuWave's full profile

SanuWave is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Sanuwave Health, Inc. CIN: 20-1176000 , United States, Active	Nov 24, 2009	$10M - $50M (As on Dec 31, 2025)	38 (As on Mar 31, 2023)	-
Sanuwave, Inc. CIN: 1471736 , United States, Active		$1 - $1M (As on Sep 17, 2009)	-	-

SanuWave got listed on Nov 13, 2009.

Click here to take a look at SanuWave's IPO in detail

SanuWave has raised a total funding of $1.43M over 19 rounds. Its first funding round was on Sep 17, 2009. SanuWave has 2 institutional investors.

Here is the list of recent funding rounds of SanuWave:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 18, 2024	4703473	Post IPO	3693745	4357138	7080893	4435543
Jan 21, 2024	9463249	Post IPO	9339267	2307285	5212950	1072097
Dec 30, 2023	7626020	Post IPO	9032119	5456511	6707397	1349568

Access funding benchmarks and valuations. Sign up today!

View details of SanuWave's funding rounds and investors

SanuWave's employee count trend

SanuWave has 80 employees as of Jun 26. Here is SanuWave's employee count trend over the years:

Uncover SanuWave's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SanuWave include SolasCure, Nuo Therapeutics and Sanara MedTech. Here is the list of Top 10 competitors of SanuWave, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SolasCure 2017, Cambridge (United Kingdom), Series B	Developer of biologic therapies for the treatment of chronic wounds	$34.1M	Seneca, Tricor Group & 66 others	62/100
2nd	SanuWave 2005, Alpharetta (United States), Public	Developer of Noninvasive devices, and biologics for wound healing	$1.43M	CIT, Kingswood Capital Markets	60/100
3rd	Nuo Therapeutics 2001, Gaithersburg (United States), Public	Developer of regenerative products for wound care	$69.1M	MidCap Financial, Maryland Department of Commerce ... & 2 others	57/100
4th	Sanara MedTech 1982, Fort Worth (United States), Public	Developer of therapeutics for infectious disease	-	BlueIO, The Catalyst Group	56/100
5th	TargED 2020, Utrecht (Netherlands), Series A	Developer of biological drugs for the treatment of thrombosis	$82.8M	Andera Partners, Sunstone & 8 others	56/100
6th	MediWound 2001, Yavne (Israel), Public	Developer of enzymatic therapeutic solutions for tissue repair and regeneration	$18M	Point72, New Era Capital Partners & 10 others	54/100
7th	Tissue Regenix 2006, Swillington (United Kingdom), Public	Developer of regenerative medical devices by using cell technology	-	Harwood Capital, Aquarius Equity Partners ... & 2 others	53/100
8th	QBiotics 2000, Brisbane (Australia), Series C	Developer of small molecules discovered from the plant extracts	$98.1M	TDM Growth Partners, WG Partners	53/100
9th	Next Science 2012, Jacksonville (United States), Public	Redefining healing through science, innovation, and commitment to better patient outcomes	-	-	51/100
10th	BioStem Technologies 2006, Pompano Beach (United States), Public	Provider of placental-based amniotic tissue products	-	-	51/100